Journal articles: 'Siddha (Medizin)'

1

M. Chitra and Dr. C. Madhesh. "A Study On Consumer Awareness Towards Siddha Medicine In Dharmapuri City." Restaurant Business 118, no. 12 (December 6, 2019): 16–23. http://dx.doi.org/10.26643/rb.v118i12.12582.

Full text

Abstract:

Siddha is considered to be one of the oldest medicines with its own benefits. In this modern era, people are more aware towards their health. At many circumstances of illness, people use Siddha medicines to cure their disease. Siddha is preferred for its own specialties. This paper has attempted to reveal the awareness towards Siddha medicines taking 52 respondents from Dharmapuri City. The results were analysed by using various statistical techniques like percentage analysis, chi-square and t test. Siddha focuses on the eight supernatural powers called as ‘Ashtaamahasiddhi’ and those who achieved these powers were known as siddhars. Hence it is called as siddha medicine. The siddhars knowledge was found in palm leaf manuscripts and their fragments were found in some parts of south India.

APA, Harvard, Vancouver, ISO, and other styles

2

Govindhan, Sivapalan. "Siddha Medicine as Descripted in Siddhar Literature." Journal of Indian Studies 10 (May 10, 2013): 38–42. http://dx.doi.org/10.22452/jis.sp2013no1.8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Priyadarshini, S., H. Vetha Merlin Kumari, S. Mohan, and R. Meenakumari. "STANDARDIZATION OF PULIYAARAI NEI: A SIDDHA POLY HERBAL FORMULATION." International Journal of Research in Ayurveda and Pharmacy 11, no. 5 (October 30, 2020): 218–27. http://dx.doi.org/10.7897/2277-4343.1105172.

Full text

Abstract:

Siddha is one of the Indian systems of medicine which is widely practiced in Tamil Nadu, India. Siddha insists to lead a healthy life both physically and mentally. Siddhars have classified 4448 disease, based on the three humoral pathologies. Among them Ratha Moolam (Bleeding piles) is classified under Eruvaimulainoi. Puliyaarai Nei has indication for Ratha Moolam (Bleeding piles) as per siddha text Aathmaratchamirthamennumvaithiyasaarasangiragam (siddha vaithiyathinaathinool). The drug is prepared as per the method mentioned in the Siddha literature. Drug standardization of herbal formulations is essential for their acceptance in this scientific medical world. In this article Physicochemical, Phytochemical, biochemical analysis and other standardization methods of one such polyherbal medicated ghee Puliyaarai nei are discussed. The organoleptic characteristics, pH, Iodine number, Saponification value, Peroxidase value, Acid value were studied. The Qualitative study was done in biochemistry and the results are as follows, puliyaarai nei showed the Presence of carbonate, aluminium, iron, zinc, calcium, magnesium, ammonium, mercury, starch, arsenic and alkaloid. Preliminary phytochemical screening was done for the presence of flavonoids, steroids and betacyanin. HPTLC finger printing, Heavy metal analysis, Pesticide residues, Microbial contamination were studied as per the Pharmacopoeial laboratory standards of Indian medicine. In results, it was found that the specified drug was containing various phytochemicals and is free from microbial contamination, and pesticide residues. The heavy metals such as Arsenic, Mercury, Cadmium and Lead are not detected.

APA, Harvard, Vancouver, ISO, and other styles

4

Jambagi, Bankimchandra S., and Vijaykumar Chavadi. "PHARMACEUTICO-ANALYTICAL STUDY OF ADITYAPAKA GUDUCHITAILA W.S.R TO ADITYAPAKA METHOD." International Ayurvedic Medical Journal 8, no. 9 (September 23, 2020): 4411–17. http://dx.doi.org/10.46607/iamj1808092020.

Full text

Abstract:

Purpose: Taila Kalpana is one of Sneha Kalpana procedure which is widely used and mostly preferred dosage forms of Ayurvedic system of medicine. It is followed to produce an oleaginous medicament from. Taila Kalpana involves 2 methods viz, Agnipakavidhi and Adityapakavidhi. Agnipakavidhi(Heating through Fire) is a method where fire is used as source to prepare the medicine Adityapakavidhi (Heating through sunlight), where the preparation is subjected to intense heat from Sun rays until the Taila Siddhi Lakshana (Tests of perfection) are observed, Adityapaka Guduchi Taila is selected for study to Pharma-ceutical as well as Analytical parameters the results obtained are differed as compared with Agnipaka Vidhi Siddha Taila due to its unique method of preparation.

APA, Harvard, Vancouver, ISO, and other styles

5

Rageth, Nina. "A Reciprocal Relationship." Asian Medicine 13, no. 1-2 (September 10, 2018): 222–46. http://dx.doi.org/10.1163/15734218-12341414.

Full text

Abstract:

AbstractThis article studies the interplay between Siddha medicine and Santhigiri, a Hindu guru organization in South India. Based on insights gained through ethnographic research in Kerala and Tamil Nadu, it analyzes how Santhigiri fashions itself as an indispensable actor in the restoration of Siddha medicine and valorizes its current Siddha medical activities. The article examines the dynamics that facilitate Santhigiri’s patronage of Siddha medicine and contribute to its continuing participation in the Siddha medical system. This social formation is conceptualized through the Bourdieusian framework of capital, arguing that Santhigiri’s appropriation of Siddha medicine bestows symbolic capital upon the organization, enabling it to secure and maintain a favorable position in the field of Hindu guru organizations. Furthermore, the article shows how, by adopting Siddha medicine, a religious organization such as Santhigiri with the necessary structural and financial means and a reputation for transcending economic interests extends the distribution of Siddha medicine beyond the Tamil community. Thus, the article emphasizes the reciprocal relationship between a religious organization and a medical system, arguing for the explanatory potential of conceiving of medicine as effective capital for religious organizations and, vice versa, of religious organizations as actors shaping the realm of medicine in India.

APA, Harvard, Vancouver, ISO, and other styles

6

Gnanasoundran, Vanitha, and Thanigaivelan Dhandayuthapani. "Siddha medicine practitioners and their knowledge, attitude and practice about tuberculosis patients: an observational study in Tamil Nadu, India." International Journal of Research in Medical Sciences 7, no. 2 (January 25, 2019): 532. http://dx.doi.org/10.18203/2320-6012.ijrms20185503.

Full text

Abstract:

Background: Siddha medicine is one of the commonest alternative medicine among AYUSH (ayurveda, yoga and naturopathy, unani, siddha, homeopathy) medicine practiced in Tamilnadu, one of the southern states of India, where it originated originally. To assess the knowledge, attitude and practice of siddha medicine practitioners towards Tuberculosis, a leading infectious disease-causing increased mortality and morbidity in the country where world’s one fifth of the diseased patients of tuberculosis live and how these alternative medicine practitioners are helping the national programme of eradicating TB in 2025 with their practice.Methods: A Questionnaire was prepared regarding the symptoms, investigations, treatment of TB and about its knowledge of recent trend. One siddha medicine practitioner was randomly selected from the 32 districts of the state from the registry, interviewed and assessed.Results: Out of the 32 siddha practitioners interviewed, 96% referred the tuberculosis patients to the nearby government hospitals for the antituberculous treatment but with the supportive siddha medicine. Regarding the awareness or update of the recent change in the TB regime and the national programme, only 10% of the siddha medicine practitioners were sensitised that too only those working in government hospitals.Conclusions: Siddha medicine practitioners mostly referred the tuberculosis patients, but they are insisting on the supportive role of siddha medicine along with the standard anti tuberculous drugs for the general improvement of the patient. Also, the sensitisation programmes for these Siddha practitioners should be initiated for the better outcome of the RNTCP (Revised National Tuberculosis Control Programme), especially in the private setup.

APA, Harvard, Vancouver, ISO, and other styles

7

Subbarayappa, BV. "Siddha medicine: an overview." Lancet 350, no. 9094 (December 1997): 1841–44. http://dx.doi.org/10.1016/s0140-6736(97)04223-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

A, Anand Ganapathy, Alaganandam Kumaran, and Lekha G. S. "A Review on Prevention of COVID 19 - Siddha perspective." International Journal of Ayurvedic Medicine 11, no. 4 (December 9, 2020): 594–615. http://dx.doi.org/10.47552/ijam.v11i4.1698.

Full text

Abstract:

Introduction: Siddha is one of the ancient traditional medicine systems originated in South India which incorporates the extensive use of herbs, inorganic substances and animal products for maintaining a healthy life. Siddha system of medicine (SSM) has diverse and extensive use of natural resources for the prevention and management of comorbid conditions, widespread epidemic or pandemic diseases. Methodology: This article is the review on Siddha literatures, research and review articles in Google Scholar, major scientific databases such as SciFinder, Pubmed, Scopus, Science Direct and Springer using the major terminologies COVID-19, SARS-CoV-2, epidemic, immune-modulatory, antiviral, environmental sanitization and Siddha. The collected data’s are extracted as SARS-COV-2 outline, Basic concepts, communicable diseases and preventive measures revealed in Siddha system of Medicine. Moreover the authors have tabulated the herbs used as health promoters and immune-modulators in Siddha, herbs used for fumigation and sanitization and the herbal ingredients used in important Siddha formulations for the management of infectious diseases. Conclusion: Many of the active principles present in the herbs are studied, proven to be effective immune-modulators, antivirals, anti-asthmatic and anti-inflammatory agents, which may also be effective towards the control of COVID-19. However, further scientific studies and data are required to support the use of Siddha medicines and herbs.

APA, Harvard, Vancouver, ISO, and other styles

9

Janani, Singarajah, and Antony Duraichi R. "Siddha Formulation Kadikara Chendooram: A Drug Review." International Journal of Health Sciences and Research 11, no. 4 (April 14, 2021): 190–96. http://dx.doi.org/10.52403/ijhsr.20210425.

Full text

Abstract:

Traditional system of healing that originated in South India and considered to be one of Indian’s oldest systems of medicine. The Siddha system of medicine described about 32 forms of internal medicines in Siddha text. Among these forms, Chendooram is the one form of internal medicine. The aim of this drug review is to validate the Siddha meto- mineral formulation Kadikara chendooram with scientific evidences. The medicinal uses and therapeutic actions of the part of each ingredient used in this formulation matched with current research findings from various research publications. Through this extensive review on Siddha and recent research reports minimal scientific validation has been carried out on various pharmacological actions and therapeutic benefits of each ingredient of Kadikara chendooram. The ingredients present in this formulation have effective in the treatment of Hemiplegia and diarrhea / dysentery. Based on this evidence of Siddha literature and the modern scientific research studies also provide keyhole which result are Anti-Platelet aggregation, Thrombolytic, Anti-diarrhoeal, Antimicrobial activities most presents in ingredient of Kadikara chendooram as evident from the current review. Key words: Kadikara chendooram, Hemiplegia, Siddha system.

APA, Harvard, Vancouver, ISO, and other styles

10

S., Bhani. "Traditional Siddha Medicine The Ancient Art Of Siddha Pulse Diagnosis." Journal of Indian Studies 10 (December 23, 2020): 83–88. http://dx.doi.org/10.22452/jis.sp2013no1.15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Sri D, Packia, and Kingsly A. "FTIR Analysis of Siddha Medicine Chandra Prabhava Chendooram." International Journal of Health Sciences and Research 11, no. 5 (May 7, 2021): 133–35. http://dx.doi.org/10.52403/ijhsr.20210519.

Full text

Abstract:

Background: The Siddha system of medicine is one among part of the AYUSH system. The Siddha medicine is used to treat various diseases, especially in Genital tract diseases. In siddha system medicines were prepared from Herbals, Minerals, salts, and Metals as well as the marine and animal products are also used in the system. The drug CHANDRA PRABHAVA CHENDOORAM is basically a crystal powder in nature which is used in Siddha medicine for Genital tract disorders. Objective: To explore the elemental characterization of the mineral Chandra prabhava chendooram. Methods: The Functional Group studied through FTIR study. It can be correlated in WHO recommended parameters for confirmed the standardizations in above drug. Results: In FTIR studies should markedly increase value from 3678.25 to 3745.76 respectively, which is indicated it contains most of them. Conclusion: All the modern scientific parameters provide it is minimal size particles and good characteristic nature of the drug. So, Chandra prabhava chendooram is highly therapeutic and bio availability value used cured in genital tract disease. Key words: Chandra prabhava chendooram, FTIR, Siddha Medicine, genital tract disease.

APA, Harvard, Vancouver, ISO, and other styles

12

V, Rekha, and Essakky Pandian G. "Review on Siddha Drug: Panchalavana Parpam." International Journal of Health Sciences and Research 11, no. 5 (May 7, 2021): 128–32. http://dx.doi.org/10.52403/ijhsr.20210518.

Full text

Abstract:

In Siddha system, medicine includes the herbal products, inorganic substances and animal products that lead to different formulations ranging from low shelf life drug to high shelf life drug. Parpam is the powdered substance generally obtained by calcification of purified metals, minerals and animal products by specific process. The current review aims to explore about Siddha formulation “Panchalavana Parpam” for the management of Kiraani and associated symptom. The details about the Siddha formulation “Panchalavana Parpam” was acquired from Siddha text Boghar 700: Pg. No: 49 and the details of each ingredients of above drug were collected from various Siddha texts. According to the results, all five ingredient of this preparation having the potency of relieving Soolai, Kiraani, gunmam, like gastero intestinal tract diseases. This preliminary literature review related research provides useful documentary evidences for medicinal ingredients those are commonly using to prepare the medicine for health management. Key words: Panchalavana Parpam, gunmam, Kiraani Siddha system.

APA, Harvard, Vancouver, ISO, and other styles

13

S, Vigneshwari, and Antony Duraichi R. "Scientific Validation on the Effect of Siddha Sashtric Formulations in Chemotherapy Induced Nausea and Vomiting – A Review." International Journal of Health Sciences and Research 11, no. 4 (April 14, 2021): 182–89. http://dx.doi.org/10.52403/ijhsr.20210424.

Full text

Abstract:

Siddha system is one of the major Indian systems of medicine. Siddha sashtric formulations are used for the treatment and management of non communicable diseases like stroke, cancer, diabetes, chronic lung diseases etc. Of these, cancer is the second leading cause of death globally. CINV is a significant burden for patients undergoing anticancer therapy. Nausea and vomiting are rated as two of the most distressing symptoms by chemotherapy patients and have been shown to significantly and adversely affect quality of life and physical function during treatment (Carelle et al., 2002). Many siddha sashtric formulations are available for nausea and vomiting. All of the available information about Siddha anti emetic Formulations, their ingredients and chemical constituents were collected from the rich collection of ancient Siddha books held in the library, Government Siddha Medical College, Palayamkottai, Tirunelveli. Electronic searches also made. They also have the therapeutic actions like anticancer, antioxidant, anti inflammatory, chemo preventive, gastro protective etc. This review explains the scientific evidences for the effect of Siddha Sashric formulations in the treatment and management of chemotherapy induced nausea and vomiting. This documentation provides the baseline information about the therapeutic importance of Siddha medicines in chemotherapy induced nausea and vomiting and it will be useful for further clinical trials. Key words: Siddha medicine, cancer, chemotherapy, CINV, nausea and vomiting.

APA, Harvard, Vancouver, ISO, and other styles

14

Rathinam, Susila, Kannan Muthiah, Sathiyarajeswaran Parameswaran, Kavitha Tamilarasan, Esaivani Selvarajan, and Usha Ayyasamy. "Analogy of Kaba Suram with COVID-19 Symptoms - A Siddha Literature Review." International Journal of Ayurvedic Medicine 11, no. 4 (December 9, 2020): 616–21. http://dx.doi.org/10.47552/ijam.v11i4.1674.

Full text

Abstract:

Kaba Suram (phlegmatic fever) is one among the 64 types of Suram (Pyrexia/fever), its synonyms, causes, pathology and characteristics have been mentioned crystal clear in Siddha literature. Its clinical features have been mentioned in few literatures such as Theran karisal, Suravagadam, Yugi chinthamani etc., which are almost similar to each other. The present day pandemic disease COVID-19 which still lacks specific drug towards its management or prophylaxis has become the spectrum of research focus in current scenario. Upon keen understanding of the Siddha literature the signs and symptoms of Kaba Suram fall in line with COVID-19 and a few other flu like illnesses. Therefore, the herbal decoction Kaba Sura Kudineer (KSK) indicated for the management of Kaba Suram has been recommended by the Siddha research community towards an integrated approach in tackling this worldwide emergency. The current scientific community demands evidence based explanation to understand the concept of Siddha system of medicine and necessitates International standards to reassure the efficacy of Siddha medicine. In this aspect, this review is aimed at evaluating all the available informations on Kaba Suram in Siddha literature and pathophysiology of COVID-19 and to interpret the search results in terms of pathophysiology of Kaba Suram based on Mukkutram theory. This effort would therefore enable the Siddha research community to opt for effective Siddha medicines to manage the present pandemic situation.

APA, Harvard, Vancouver, ISO, and other styles

15

Manthiramoorthiyapillai, S. "Siddha Medicine and Mental Illness." International Journal of Social and Economic Research 2, no. 2 (2012): 363. http://dx.doi.org/10.5958/j.2249-6270.2.2.035.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

M.G.L., Velayutham. "Siddha Medicine-A Short Introduction." Journal of Indian Studies 10 (October 17, 2020): 6–11. http://dx.doi.org/10.22452/jis.sp2013no1.2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Samraj, K., K. Nandhagopal, S. Radha, S. Rajalakshmi, K. Arunachalam, and K. Kanakavalli. "A National Web Conference on Integrated Siddha Approach in Clinical Practice and Research on COVID-19 Pandemic (ISACC)- Tirupati, December 2020." Journal of Natural Remedies 21, no. 3 (July 6, 2021): 259. http://dx.doi.org/10.18311/jnr/2021/27282.

Full text

Abstract:

Siddha Clinical Research Unit (SCRU) Tirupati, working under the Central Council for Research in Siddha (CCRS), Ministry of AYUSH, Govt. of India, conducted a National Web conference titled “Integrated Siddha Approach in Clinical Practice and Research on COVID-19 Pandemic (ISACC)” on 23<sup>rd</sup> Dec 2020, as a part of the fourth Pre-Siddha Day observance. Totally, 256 participants from Siddha colleges and various institutes of CCRS attended the Web conference and 9 eminent Speakers share their knowledge at the conference. The Technical session was separated by three panels, (i)Siddha Standalone and Integrative Clinical trials on COVID-19, (ii)Siddha Preventive and Prophylactic Measures on COVID-19, (iii)Experiences in Siddha Integrative Clinical Practice on COVID-19. The take home message of the conference insisted upon the three facts - the need for more clinical trials , need for increased experience sharing platforms for Siddha medical system and finally that Siddha standalone as well as integration for COVID-19 management gave significant outcome in both preventive and promotive healthcare. Central Council for Research in Siddha (CCRS), Ministry of AYUSH, Govt. of India and Directorate of Indian Medicine and Homeopathy (DIM&H), Government of Tamil Nadu, contributed a lot in Research and services in COVID-19 pandemic.

APA, Harvard, Vancouver, ISO, and other styles

18

M, Shakthi Priya, and Essakky Pandian G. "Drug Review on Siddha Drug - Thirikadugadhi Mandooram." International Journal of Health Sciences and Research 11, no. 5 (May 7, 2021): 140–45. http://dx.doi.org/10.52403/ijhsr.20210521.

Full text

Abstract:

Siddha system is an oldest system of traditional medicine originating in ancient Tamilnadu in South India. In Siddha system, medicine includes the herbal products, inorganic substances and animal products that lead to different formulations ranging from low shelf life drug to high shelf life drug. Thirikadugadhi Mandooram is a poly herbo-mineral formulation used to treat Anaemia, Jaundice, Anasarca, Fever, Tuberculosis. This review describes the phytochemicals, pharmacological action and medicinal uses of the part of each ingredient used in this formulation. Ingredients of the formulation and their pharmacological action in various research studies are discussed in this review. The details were collected from different Siddha texts and electronic databases. In conclusion the results of the review revealed that the pharmacological action and the medicinal uses of drug were perfectly matched with each ingredients of formulation. Key words: Siddha system, Thirikadugadhi Mandooram, review.

APA, Harvard, Vancouver, ISO, and other styles

19

Sendhilkumar Muthappan, Muralidass SD, Eswaran Chinraji, and Mantela Durairajan. "Concept and description of Madhumegam (Diabetes mellitus) in Siddha System of Medicine." International Journal of Research in Pharmaceutical Sciences 11, no. 2 (March 28, 2020): 1302–4. http://dx.doi.org/10.26452/ijrps.v11i2.1985.

Full text

Abstract:

Rapid socio-economic development and demographic changes, along with an increased susceptibility for Indian individuals, have led to the explosive increase in the prevalence of Diabetes Mellitus in India over the past four decades. Siddha System is one of the oldest Traditional Systems of Medicine in India and predominantly practiced in southern India especially in Tamil Nadu. The vital part of Siddha Medicine is to revitalize and rejuvenate dysfunctional organs that cause the disease and to maintain a healthy body and mind. According to Siddha, all objects and living bodies are composed of five basic structural elements (Panchabhutams), namely earth, water, fire, air, and vacuum (ether). Siddha believes in the theory of Tridoshams, namely wind (Vaatham), bile (Piththam), and phlegm (Kabam). The Madhumegam has 20 types which divided into Vaatham- 4, Piththam- 6 and Kabam- 10 types. Madhumegam is a clinical condition characterized by the frequent passage of urine more than the normal resulting in deterioration and diminution of Seven Thathus. The diagnosis in the Siddha system is based on the Land (Nilam), Season (Kaalam), Pori alaridhal, Pulan alarithal, Threedosham status (Mukkutra Nilaigal), Udal Thathukal Nilai and Envagai Thervugal. As the researchers looking an alternative way for treating this high burden disease, it is the need of the hour to invests more on to create the evidence to prevent, control and treat this high burden disorder by synthesizing the evidence from the Siddha.

APA, Harvard, Vancouver, ISO, and other styles

20

Sébastia, Brigitte. "Preserving Identity or Promoting Safety? The Issue of Mercury in Siddha Medicine: A Brake on the Crossing of Frontiers." Asiatische Studien - Études Asiatiques 69, no. 4 (December 1, 2015): 933–69. http://dx.doi.org/10.1515/asia-2015-1043.

Full text

Abstract:

Abstract Since the publication of a sanitary alert on the toxicity of ayurvedic products by Robert B. Saper and colleagues in the Journal of the American Medical Association (JAMA) in 2004, the image of ayurveda as a safe alternative or complement to biomedicine has sharply deteriorated in North America and Europe. In reaction, some western countries have forbidden the import of the herbal products denounced by Saper and colleagues’ warning, and the Government of India has taken measures to implement its rules on their production to ensure the full safety of the products intended for both export and national markets. This seriously hinders the export of siddha remedies as they may contain metals, mercury being one of their iconic ingredients. It has also created problems for their production, as the companies that manufacture siddha products are, in general, less developed than their ayurvedic counterparts. I will discuss this event and its impact on regulations in Europe, the United States and Canada and in India in the first part of this chapter. In the second part, I will explore the ideological and spiritual position of siddha medicine and its relation to iatrochemistry in order to comprehend why it has the reputation of a metal- and mineral-based medicine, and in particular, a mercury-based medicine. The third part, based on research conducted in 2007 on private and governmental siddha firms and the traditional siddha milieu throughout Tamil Nadu, will focus on the production of siddha medicaments and their marketing, as well as on the diverse means by which they cross frontiers for consumption abroad.

APA, Harvard, Vancouver, ISO, and other styles

21

Murogaiah, Annadurai. "Siddha Medicine and Disease Free Life." Journal of Indian Studies 10 (December 23, 2020): 112–19. http://dx.doi.org/10.22452/jis.sp2013no1.19.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Jeyanthi, A. "A Review on Antidiabetic Potential of Herbals in Siddha Medicine." Journal of Medical Science And clinical Research 05, no. 06 (June 16, 2017): 23451–55. http://dx.doi.org/10.18535/jmscr/v5i6.108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Neela, M. "A Review on Anthelmentic Potential of Herbs Mentioned in Siddha Medicine." Journal of Medical Science And clinical Research 05, no. 02 (February 7, 2017): 17432–36. http://dx.doi.org/10.18535/jmscr/v5i2.36.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

M., Meenakshi Sundaram, Logamanian M., and Banumathi V. "Paediatric Management in Siddha System of Medicine." International Journal of Advanced Ayurveda, Yoga, Unani, Siddha and Homeopathy 6, no. 1 (July 22, 2017): 370–77. http://dx.doi.org/10.23953/cloud.ijaayush.282.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Sabarianandh, JV, Kumarappan Manimekalai, and Lazer Bernaitis. "COVID-19 in Siddha Medicine: A Review." SBV Journal of Basic, Clinical and Applied Health Science 3, no. 2 (2020): 83–86. http://dx.doi.org/10.5005/jp-journals-10082-02256.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Somasundaram, O., T. Jayaramakrishnan, and M. Sureshkumar. "Psychiatry in Siddha (Tamil) System of Medicine." Indian Journal of Psychological Medicine 9, no. 1 (January 1986): 38–45. http://dx.doi.org/10.1177/0975156419860108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

K, Jayashree, and Kingsly A. "Therapeutic Effectiveness of a Siddha Formulation Arootha Chooranam: A Review." International Journal of Health Sciences and Research 11, no. 5 (May 7, 2021): 146–50. http://dx.doi.org/10.52403/ijhsr.20210522.

Full text

Abstract:

Siddha system of medicine is the one of the ancient system of medical practiced among Tamil speaking community. The medicine in this system prepared from raw drug from only herbals. Arootha chooranam is a herbal preparation with ingredients of 9 herbals. It’s used to treat the sexual desire disease particularly for indiriyanastam [pre mature ejaculation]. This review is aimed to bring out scientific evidence for the therapeutic usage of Arootha chooranam and focused on the pharmacological activity for the curative nature of the drug. Most of the drugs have anti-oxidant activity and anti-infertility, spermatogenesis, Aphrodisiac activity hence justifying its usage in above mentioned disease. Key words: Siddha medicine, Arootha chooranam, indiriyanastam, pharmacological activity.

APA, Harvard, Vancouver, ISO, and other styles

28

D., Venkatachalam, Kalaiselvi Selvaraj, Gomathi Ramaswamy, Veerakumar A., Palanivel Chinnakali, and Ganesh Kumar Saya. "Are patients satisfied with accessibility and services provided at siddha hospitals? Findings of patient satisfaction survey from a district of South India." International Journal Of Community Medicine And Public Health 5, no. 6 (May 22, 2018): 2596. http://dx.doi.org/10.18203/2394-6040.ijcmph20182201.

Full text

Abstract:

The study was aimed to assess patient satisfaction about with services provided by Siddha (indigenous) system of medicine which was merged with public health system recently in India. A facility based cross-sectional study was conducted among the outpatients attending selected siddha hospitals in Tamil Nadu. Perception regarding the quality of services was assessed from every 10th patient visiting the hospitals during the month of February and March 2014. Of total 263 out patients interviewed, majority of them reported that the amenities related to infra-structure (47-68%) and OPD timings (96.6%) were satisfactory. However, 32% and 23% of the patients reported that seating facility and waiting time were not satisfactory respectively. Almost all patients were satisfied regarding competency, behaviour of siddha doctors and pharmacists. Of the 217 patients who revisited the siddha wing, most of the patients (98.2%) reported improvement in their illness. There is a scope to improvise the amenities related to infra-structure in these health facilities.

APA, Harvard, Vancouver, ISO, and other styles

29

Mazhar, Syeda Ayeman, Rubi Anjum, Ammar Ibne Anwar, Abdul Aziz Khan, and Muhammad Usman. "COHERENCE REVIEW OF ESSENTIAL FUNDAMENTALS OF UNANI, AYURVEDA, SIDDHA AND HOMEOPATHY SYSTEMS OF MEDICINE." Journal of Biological & Scientific Opinion 9, no. 2 (May 31, 2021): 18–24. http://dx.doi.org/10.7897/2321-6328.092142.

Full text

Abstract:

Medicine, defined as the science and practice of the diagnosis, treatment and prevention of disease. The word medicine springs from Latin medicus, meaning “physician″. According to Henry Sigerist, the medical historian has stated that every culture had developed a system of medicine and medical history is but one aspect of history of culture. India, with its rich cultural heritage, has been in the forefront in contributing to the medical sciences, and there is plenty of proof of the same. Ayurveda, Yoga and Naturopathy, Unani, Siddha, and Homeopathy (AYUSH) is one component of the six indigenous systems of medicine practiced in India. The art of tending to the sick is as antique as the humanity itself. The ancient civilizations probably knew about the functions, physiology and anatomy of the human physique in surprising details, and their art of tending the sick remains an evidence of their knowledge. The medical systems that are truly Indian in origin and development are Ayurveda and as well the Siddha system. Unani-Tibb and Homeopathy, though not of Indian origin, have a significant importance in health care in India. Today, India is among the leading countries as far as the practice of Unani medicine is concerned. This paper will be an attempt in analysing the insights of various fundamental principles and key concepts of Unani, Ayurveda, Siddha and Homeopathy along with their differential aspects.

APA, Harvard, Vancouver, ISO, and other styles

30

Sathyaseela R, Kamalinie R, Bupesh G, Baskar M, and Vasanth S. "Anti Inflammatory effect of Bacopa Monnieri ( Brahmi) on Swollen Joints – A Case Study." International Journal of Research in Pharmaceutical Sciences 11, no. 3 (July 23, 2020): 4074–77. http://dx.doi.org/10.26452/ijrps.v11i3.2607.

Full text

Abstract:

The arthritis is a chronic, inflammatory, autoimmune disease characterized by Pain, edema and stiffness of the joints. Chronic stages of arthritis causes swelling in and around the affected joints. The Siddha herbal medicines are becoming familiar as they possess less adverse effects. Plenty of antiinflammatory herbs are described in Siddha system of medicine. The plant, bacopa monnieri maintains its original place in the management of various diseases, including arthritis, and acts as anti-inflammatory drug. Hardly a few studies are available to prove the antiarthritic and anti-inflammatory properties of Bacopa monnieri. In ancient Siddha literature Bacopa has been highlighted for its antiarthritic properties especially prescribed to reduce the swelling caused by increased synovial effusion. The current study is aimed to assess the antiarthritic and anti inflammatory properties of Bacopa (Brahmi) paste on swollen arthritic joints. A male patient aged 70 was selected from IPD, Pothu maruthuvam department, Sri Sairam Siddha Medical College & Research Center, Chennai -44. Bacopa Paste applied over swollen arthritic ankle joints showed good progress in very few days of treatment.

APA, Harvard, Vancouver, ISO, and other styles

31

Kumar, Neeta, Nalini Tripathi, and Mukesh Nandave. "Management of Covid-19 patients with indigenous formulations in home settings- Case reports of two patients." International Journal of AYUSH Case Reports 5, no. 2 (June 28, 2021): 98–106. http://dx.doi.org/10.52482/ijacare.v5i2.210.

Full text

Abstract:

This is to report 2 cases experiencing action of indigenous medicine in controlling Covid-19 symptoms in the home setting, without any requirement of hospitalization. Covid-19 (SARS-CoV-2), a viral disease by novel coronavirus, impacted 220 countries. Although, numerous attempts have been made for the management and treatment of Covid-19 with various drugs, traditional Ayurveda and Siddha has been widely reported to be effective in treating viral diseases through altering innate adaptive immune response and inhibition of virus attachment to body cells. It is found to inhibit attachment of virus to human cell, hence reducing viral load induced cytokine storm, inflammatory over reactions in the body of patients and inhibition of community spread. The experience of 2 cases reported here showed how senior citizens with various co-morbidities recovered from covid 19 and remained healthy without sequelae or side effects even after 6 months of follow-up. These observations are vital clues for a large population-based study and ongoing clinical trials. Mechanism of action of Sidha and Ayurvedic medicines like Kabasura Kudineer, Sitopladi, Triphala are well published and highly recommended for affecting viral entry and immune regulatory pathways. With no side effects, secondary infections and action, these regimens pave the ways for safe and effective cure for Covid-19.

APA, Harvard, Vancouver, ISO, and other styles

32

P.T., Kalaichelvan, and Akila Kalaichelvan. "Fight Cancer with Phyto-Medicine with Siddha System of Medicine." Journal of Indian Studies 10 (October 10, 2013): 129–36. http://dx.doi.org/10.22452/jis.sp2013no1.22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Sivapalan, G., and Dr S. Manimaran. "Siddha Medicine and its current status in Malaysia." Journal of Tamil Peraivu 9, no. 1 (July 20, 2020): 89–100. http://dx.doi.org/10.22452/jtp.vol9no1.10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Thileepan, Thayalini. "Literature Review of Suram(Fever) in Siddha Medicine." JOURNAL OF RESEARCH IN TRADITIONAL MEDICINE 4, no. 2 (2018): 21. http://dx.doi.org/10.5455/jrtm.2018/298118.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Rajeev, S. R. Pholtan. "DRUG RESEARCH ON SIDDHA MEDICINE; UTHTHARA RASACHENDOORAM (URC)." Asian Journal of Phytomedicine and Clinical Research 08, no. 01 (March 25, 2020): 1–11. http://dx.doi.org/10.36673/ajpcr.2020.v08.i01.a01.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

S, Ayyasamy, and Sudha R. "CHUNNAM: A COMMENDED DOSAGE FORM IN SIDDHA MEDICINE." International Journal of Research in Ayurveda and Pharmacy 4, no. 1 (February 27, 2013): 1–4. http://dx.doi.org/10.7897/2277-4343.04110.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Sudharsan, S., V. Velpandian, M. Pitchiah kumar, and V. Banumathi. "FTIR Characterization of Siddha medicine Nilapanai kizhangu chooranam." International Journal of Current Research in Chemistry and Pharmaceutical Sciences 4, no. 2 (February 15, 2017): 10–12. http://dx.doi.org/10.22192/ijcrcps.2017.04.02.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Thambyayah, Malinee, and Arul Amuthan. "Infantile seborrheic dermatitis: A pediatric Siddha medicine treatise." Clinics in Dermatology 33, no. 3 (May 2015): 355–61. http://dx.doi.org/10.1016/j.clindermatol.2014.12.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Sonitha, S., D. Sivaraman, and V. Rani. "Acute and subacute toxicity profiles on siddha drug Thulasi Ennai in wistar rats." Journal of Phytopharmacology 9, no. 6 (December 30, 2020): 403–9. http://dx.doi.org/10.31254/phyto.2020.9604.

Full text

Abstract:

Medicinal plants have been used in traditional medicines for their unmatched availability of bioactive compounds. Asthma is the most common chronic disease among children worldwide. It is ranked 16th among the leading causes of years lived with disability. Medicinal plants have placed a vital role in the siddha system of medicine over centuries to cure acute and chronic illness. The aim of the present study was to investigate toxicity analysis to evaluate safety of the siddha drug Thulasi Ennai in vivo in wistar albino rats. Thulasi Ennai is a polyherbal siddha formulation mentioned in the ancient siddha books and literature, indicated to cure childhood bronchial asthma. In this study, Thulasi Ennai administered orally at a single dose of 2000mg/kg body weight and monitored for 14 days. For subacute toxicity study, Thulasi Ennai was orally administered in different doses of 200,400mg/kg body weight, daily for 28 days. At the end of each study physical parameters, hematological, biochemical and histopathological analysis were evaluated. No animals in each group of acute or subacute toxicity study showed mortality or clinical signs of toxicity throughout the study. Hence, the results of the study indicate a safe toxicological profile of Thulasi Ennai.

APA, Harvard, Vancouver, ISO, and other styles

40

P, Sathiyarajeswaran, Shree Devi MS, Sunil Kumar Koppala Narayana, Muthu Tamizh Manoharn, Satheesh Durairaj, Brindha Sundaramoorty, Dhanaraj K, and Patturayan R. "Quality Standards for Urai Mathirai - A Siddha Immunomodulator Formulation for Children." Journal of Phytopharmacology 7, no. 1 (January 22, 2018): 40–44. http://dx.doi.org/10.31254/phyto.2018.7109.

Full text

Abstract:

Standardization of Siddha formulations is a major step for establishment of biological activity, consistent chemical profile, or quality control for production and manufacturing of herbal drugs. Urai Mathirai (UM) is a Siddha polyherbal preparation comprising of Chukku (Zingiber officinale Roscoe), Adimathuram (Glycyrrhiza glabra L.), Akkirakaram (Anacyclus pyrethrum (L.) Lag.), Vashambu (Acorus calamus L.), Catikkai (Myristica fragrans Houtt.), Katukkai (Terminalia chebula Retz.), Masikkai (Quercus infectoria G.Olivier), Acanam (Allium sativum L.), Tippili (Piper longum L.) and Perunkayam (Ferula aasa-foetida L.). UM reduces accumulated Aiyam with ingredients having hot potency which increases Azhal. As UM is an important medicine in Siddha pediatrics the current study is aimed to standardize UM employing standard testing protocol for AYUSH drugs. Macroscopic authentication, powder microscopy and physico‐chemical studies like loss on drying, water soluble ash, acid insoluble ash, ethanol soluble extractive, water soluble extractive, pH and HPTLC were performed as per standard methodology. The current study derived quality indicating botanical and chemical fingerprints routine quality check of UM

APA, Harvard, Vancouver, ISO, and other styles

41

A, Shanuvas, and Indhumathi M. "STANDARDIZATION OF SIDDHA HERBOMINERAL FORMULATION “LINGA MATHIRAI." Asian Journal of Pharmaceutical and Clinical Research 11, no. 6 (June 7, 2018): 439. http://dx.doi.org/10.22159/ajpcr.2018.v11i6.25228.

Full text

Abstract:

Objective: Linga Mathirai is traditional Siddha medicine. The medicinal plants and the herbal preparations are preferred; nowadays, due to minimal side effects and the presence of abundant antioxidants and micronutrients which possesses a better therapeutic efficiency. According to the World Health organization, the herbal medicines have been defined as those containing plant parts or plant materials in raw state or processed form containing active principles. The Siddha system of medicine encompasses around 600 medicinal plants in materia medica.Methods: Physicochemical analysis such as pH, ash values, and loss on drying is done and biochemical analysis of acid and basic radicals. Instrumental analysis of Fourier transform-infrared (FT-IR) for analyze the functional groups in the test drug, scanning electron microscope (SEM) for determine the particle size of the drug, and inductively coupled plasma-optic emission spectrometry (ICP-OES) for heavy metal analysis.Result: For standardization, organoleptic characters were done in that pH is 7.6, ash value is 1.379%, water-soluble ash is 0.294%, acid-insoluble ash is 0.871%, loss on drying in 105 is 0.483%, and disintegration time is 23 min. The functional group were analyzed by FT-IR. Then, in SEM, it has nano and microparticles. Finally, in ICP-OES, heavy metals are in permissible limits.Conclusion: This standardization helps this drug to develop in future and also to evaluate these drug scientifically by determine the toxicity of the drug and pharmacological effect.

APA, Harvard, Vancouver, ISO, and other styles

42

Shanmugasundaram Gouthaman, Roshni Saravanan, Jayaprakash Narayanan, and Arputha Selvi A. "Effectiveness Of Siddha Formulations In Treating Breast Cancer: An Evidence-Based Case Series." International Journal of Research in Pharmaceutical Sciences 12, no. 2 (June 8, 2021): 1546–51. http://dx.doi.org/10.26452/ijrps.v12i2.4738.

Full text

Abstract:

Breast cancer is one of the top-ranked cancers affecting women in the world. Although there are approved standard regimens for treatment, due to toxicological side effects, there is a demand for novel anti-cancer drugs with minimal adverse effects leading to the emergence of Indian Systems of Medicine. Natural treatment modalities such as Siddha, Ayurveda and Unani are emerging and have been given gaining importance in recent times. They have been in vogue for centuries together and have shown better prognosis over a period of time with lesser toxicity and admiring oncological results. The presentation is an evidence-based report on the cure of breast cancer using Siddha chemotherapeutic formulations.

APA, Harvard, Vancouver, ISO, and other styles

43

Mohanraj, Sasikala, Prabu D, Sunayana Manipal, Rajmohan M, and Bharathwaj V V. "EFFECT OF ANALGESIC IN SIDDHA MEDICINE: A SYSTEMATIC REVIEW." International Research Journal of Pharmacy 10, no. 11 (December 6, 2019): 5–9. http://dx.doi.org/10.7897/2230-8407.1011311.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Pandian, Jega Jothi, Sivarajasundari G.T., and Manikandan R. "Food for Thought-Principles and Practice of Siddha Medicine." Journal of Indian Studies 10 (May 10, 2013): 48–54. http://dx.doi.org/10.22452/jis.sp2013no1.10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Rajeswari, K., M. Supritha Muthu, K. Vennila, M. Meenakshi Sundaram, and R. Meenakumari. "PHYSICOCHEMICAL STANDARDISATION OF SIDDHA TABLET PREPARATION JATHIKAAI MATHIRAI." International Journal of Research in Ayurveda and Pharmacy 12, no. 4 (August 28, 2021): 87–93. http://dx.doi.org/10.7897/2277-4343.1204112.

Full text

Abstract:

The aim of this study is to standardize the herbal Mathirai preparation Jathikaai Mathirai based on qualitative and quantitative methods as per the analytical specifications of Tablet/Mathirai prescribed by the Protocol testing of ASU drugs by Pharmacopoeial laboratory for Indian Medicines. The Tablet is prepared as described in the text Bala Vagadam. The medicine is subjected to Physicochemical standardisation as per the pharmacopoeial laboratory standards of Indian medicine. The tablet is in solid form which is brown in colour. It is rigid with strong characteristic odor. The aflatoxin assay and pesticide residue revealed that the tablet is free of aflatoxins and pesticide residue. The formulation is free of microbial contamination and shows positive for the presence of steroids, alkaloids, coumarins, tannins, carbohydrates, glycosides etc. The heavy metals are below detectable limit. The result of HPTLC finger printing of the drug at UV 366 nm shows that the peak at Rf 0.02 constitutes 100% of the total area of the separated peaks, which denotes the abundant existence of the drug at minimum peak level itself. It indicates drug as phytochemicals. The result of the present study ensures the safety profile of the Jathikaai Mathirai – Siddha herbal Tablet intended for paediatric usage and indicative of presence of active phytoconstituents that are responsible for its efficacy in treating the Valippu Noi (Seizure disorder) in children.

APA, Harvard, Vancouver, ISO, and other styles

46

S, Thillaivanan, Velvizhi I, Sathiyarajeshwaran P, Susikannamma S, Parthiban P, Ganesh V, and Shanmugasundaram A. "An Open-Label Clinical Trial to Evaluate the Safety & Efficacy of Siddha Sastric Medicines – Fixed Regimen in COVID-19 Positive Asymptomatic, Mild or Moderate cases - A Pilot Study." International Journal of Ayurvedic Medicine 12, no. 2 (June 29, 2021): 347–52. http://dx.doi.org/10.47552/ijam.v12i3.1832.

Full text

Abstract:

Background: Covid-19 is a global pandemic since 2019. SARS-CoV2 is a new virus that originated from China and is currently spread across 160 countries. Siddha medicine is one of the traditional Indian medicines, part of Ayush that tend to treat several acute and chronic diseases. Aim: The objective of this study is to observe the safety and efficacy of Siddha regimen with lab parameters like LFT, RFT, RT-PCR, LDH, FERRITIN levels, and prevention of disease complications in covid-19 positive patients on the 7th day of treatment. Experimental Procedure: A non-randomized open-label observational retrospective study was designed. Twenty patients of either sex, of age between 18 and 60 years, were selected with proper consent. The covid patients who were confirmed by positive RT-PCR test results with or without clinical features of covid-19 were selected. They were treated with Siddha Regimen for seven days. Results: Sixteen out of 20 cases turned RT-PCR negative on their 7th day of treatment. And the Ct value of RT-PCR was statistically significant. LDH and Ferritin levels were reduced after the treatment even though the before treatment values are in the normal range. The LDH level was statistically significant on the 7th day of treatment. No Remarkable changes in the safety laboratory parameters like SGOT, SGPT, Blood urea, Serum Creatinine. Conclusion: Significant changes in efficacy laboratory parameters and no changes in safety laboratory parameters have been reported in the Siddha fixed regimen for covid-positive patients. All the 20 study participants were recovered without emergency and hospitalization.

APA, Harvard, Vancouver, ISO, and other styles

47

K., Sillalee. "Spiritualism and Siddha Medicine as Portrayed By TV Serial 'Sivamayam'." Journal of Indian Studies 10 (May 10, 2020): 55–58. http://dx.doi.org/10.22452/jis.sp2013no1.11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

T. Prakash Rao, Dr, Dr S.K. Gopi, Dr M. Regunatha Sethupathy, and Dr S. Sundararajan. "Review of herbs for Nervine tonic in traditional Siddha Medicine." International Journal of Current Research in Chemistry and Pharmaceutical Sciences 4, no. 7 (July 30, 2017): 1–7. http://dx.doi.org/10.22192/ijcrcps.2017.04.07.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Sowmyalakshmi, Srinivasan, Mohammad Nur-e-Alam, Mohammed A. Akbarsha, Subbiah Thirugnanam, J�rgen Rohr, and Damodaran Chendil. "Investigation on Semecarpus Lehyam?a Siddha medicine for breast cancer." Planta 220, no. 6 (October 28, 2004): 910–18. http://dx.doi.org/10.1007/s00425-004-1405-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

D, Muralidass S., and Shree Devi M S. "A Review on Efficacy of Siddha Medicinal Herbs as Antiviral Drugs against COVID-19." International Journal of Ayurvedic Medicine 12, no. 1 (March 31, 2021): 1–6. http://dx.doi.org/10.47552/ijam.v12i1.1741.

Full text

Abstract:

In a very short time, the Coronavirus disease (COVID-19) caused by the SARS-CoV-2 virus, has become a global pandemic. It has infected about 29,155,581 patients and brought forth death rate about 926,544 among 216 countries as recorded by World Health Organization on 15th September 2020. At present, there is no specific and direct treatment or vaccine for this infectious disease. No therapeutic options available to cure the infection in till date which increases the mortality rate across the countries. Currently there is no antiviral treatments have been approved, several approaches have been proposed in western medicine, Chinese medicine, CAM, AYUSH and other systems. Siddha Herbal medicines are achieving high attention because of the extensive therapeutics like potent anti-microbial, immunomodulatory, anti-inflammatory, and antioxidant properties. Ministry of AYUSH, Govt. of India recommended 12 Siddha herbals (Inji – Zingiber officinale, Thulasi – Ocimum sanctum, Milaku – Piper nigrum, Karunjeeragam – Nigella sativa, Keezhanelli – Phyllanthus niruri, Adhimathuram – Glycyrrhiza glabra, Vellaippoondu – Allium sativum, Citramutti – Sida cardifolia, Seenthil – Tinospora cordifolia, Manjal – Curcuma longa, Elumitchai – Citrus lemon and Vembu – Azadirachta indica) for the prevention by enhancing immunity as well as for the management of this infectious disease in its recent official publication ‘Guidelines for Siddha Practitioners for COVID 19’. This is the common advisory and the anti-viral activity of these herbals against COVID 19 is not established yet. The current situation demands proper herbal drug utilization to prepare the population immunity to fight against the infection. The present review spotlight on the literature review and the review of pharmacological actions of these herbals.

APA, Harvard, Vancouver, ISO, and other styles

Journal articles on the topic 'Siddha (Medizin)'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles